Axs Investments LLC I Bio, Inc. Transaction History

Axs Investments LLC

  • $354 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$0.55 - $1.04 $24,107 - $45,585
-43,832 Closed
0 $0
Q3 2021

Nov 05, 2021
BUY
$1.06 - $1.52 $46,461 - $66,624
43,832 New
43,832 $46,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.7M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Axs Investments LLC Portfolio

Follow Axs Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axs Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email